• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number CXT281412
Medical Device Problem Code Difficult or Delayed Separation (4044)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/16/2025
Type of Reportable Event Malfunction
Event or Problem Description
On (b)(6) 2025, this patient underwent reintervention to treat an endoleak from a previous endovascular treatment with endologix devices (date unknown).During the procedure it was reported that during deployment of the gore® excluder® conformable aaa endoprosthesis, during removal of the constraining mechanism and deployment of the secondary sleeve, the physician slid the red safety lock back and rotated the transparent knob and encountered resistance during deployment.It is believed the transparent knob was turned the wrong way leading to deployment resistance and the lock pin disengaging.The device was successfully deployed without incident and as intended.The patient tolerated the procedure with good results.
 
Additional Manufacturer Narrative
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Additional Manufacturer Narrative
The device evaluation performed by engineering showed the following: as returned, the loop guide tube (a component of the device handle) was damaged and had been detached from its intended location.The loop guide tube was returned on the constraining loop component, which was also damaged.There was also damage to other internal components of the handle, the spine adaptor and ring assembly had become detached from the spine.The state of the retuned device is consistent with a forceful rotation of the transparent knob.This is consistent with the reported event ¿the physician slid the red safety lock back and rotated the transparent knob and encountered resistance during deployment.It is believed the transparent knob was turned the wrong way leading to deployment resistance¿.No manufacturing deficiency was identified, therefore, per engineering evaluation task procedure a capa request was not generated, and this type of event will continue to be monitored through the procedure for event trending, analysis, and review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
laura crawford
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key23385877
Report Number3007284313-2025-04336
Device Sequence Number15651158
Product Code MIH
UDI-Device Identifier00733132651054
UDI-Public(01)00733132651054(17)280731
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P200030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberCXT281412
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/16/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date10/24/2025
Supplement Report FDA Received Date11/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/02/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age79 YR
Patient SexMale
Patient Weight82 KG
-
-